Deutsch English Français

Contact

EP1442744

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1442744

EP1442744 - EP4 receptor ligand and use against neuropathic pain, colon cancer, HIV and migrane [Right-click to bookmark this link]
Former [2004/32]	Use of EP4 receptor ligands in the treatment of, inter alia, neuropathic pain and colon cancer
	[2006/27]
Status	No opposition filed within time limit Status updated on 26.10.2007 Database last updated on 15.07.2024
Most recent event Tooltip	28.08.2009	Lapse of the patent in a contracting state New state(s): CY, LU	published on 30.09.2009 [2009/40]
Applicant(s)	For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN / GB
	[N/P]
Former [2006/51]	For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 ONN / GB
Former [2004/32]	For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 ONN / GB
Inventor(s)	01 / Bamford, Mark, GlaxoSmithKline New Frontiers Science Park South Third Avenue Harlow Essex, CM19 5AW / GB
	02 / Green, Richard Howard Deceased / GB
	03 / Coles, Richard GlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire, SG1 2NY / GB
	[2004/32]
Representative(s)	Cooke, Tracey, et al GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB
	[N/P]
Former [2004/32]	Cooke, Tracey (GB), et al GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road GB-Brentford, Middlesex TW8 9GS / GB
Application number, filing date	04075431.9	08.08.2000
	[2004/32]
Priority number, date	GB19990018745	10.08.1999 Original published format: GB 9918745
	GB19990028437	01.12.1999 Original published format: GB 9928437
	[2004/32]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP1442744
	Date:	04.08.2004
	Language:	EN
	[2004/32]
	Type:	A3 Search report
	No.:	EP1442744
	Date:	06.04.2005
	[2005/14]
	Type:	B1 Patent specification
	No.:	EP1442744
	Date:	20.12.2006
	Language:	EN
	[2006/51]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	18.02.2005
Classification	IPC:	A61K31/4035, A61P35/00, A61P25/02, A61P25/06, A61P31/18, C07D209/64	[2006/28]
	CPC:	A61K45/06 (EP,US); A61K31/00 (EP,US); A61K31/4035 (EP,US); A61P25/00 (EP); A61P25/02 (EP); A61P25/06 (EP); (+) A61P29/02 (EP); A61P31/18 (EP); A61P35/00 (EP) (-)
	Former IPC [2004/32]	A61K31/4035, A61P35/00, A61P25/02
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2004/32]
Title	German:	EP4 Rezeptor Ligand und Verwendung gegen neuropatischen Schmerzen, Colon Krebs, HIV und Migräne	[2006/27]
	English:	EP4 receptor ligand and use against neuropathic pain, colon cancer, HIV and migrane	[2006/27]
	French:	Ligand du récepteur EP4 et utilisation contre les douleurs neuropathiques, le cancer du colon, le HIV et la migraine	[2006/28]
	Former [2004/32]	Verwendung von EP4 Rezeptor Liganden zur Behandlung von, unter anderem, neuropatischen Schmerzen und Colon Krebs
	Former [2004/32]	Use of EP4 receptor ligands in the treatment of, inter alia, neuropathic pain and colon cancer
	Former [2004/32]	Utilisation de ligands du récepteur ep4 pour le traitement de, entre autres, douleurs neuropathiques et cancer du colon
Examination procedure	12.02.2004	Examination requested [2004/32]
	17.01.2006	Despatch of a communication from the examining division (Time limit: M04)
	15.05.2006	Reply to a communication from the examining division
	22.06.2006	Communication of intention to grant the patent
	18.10.2006	Fee for grant paid
	18.10.2006	Fee for publishing/printing paid
Parent application(s) Tooltip	EP00956408.9 / EP1202730
Opposition(s)	21.09.2007	No opposition filed within time limit [2007/48]
Fees paid	Renewal fee
	12.02.2004	Renewal fee patent year 03
	12.02.2004	Renewal fee patent year 04
	06.08.2004	Renewal fee patent year 05
	08.08.2005	Renewal fee patent year 06
	07.08.2006	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	20.12.2006
	CH	20.12.2006
	CY	20.12.2006
	DK	20.12.2006
	FI	20.12.2006
	LI	20.12.2006
	NL	20.12.2006
	SE	20.03.2007
	GR	21.03.2007
	PT	24.04.2007
	IE	08.08.2007
	LU	08.08.2007
	MC	31.08.2007
	[2009/40]
Former [2008/45]	AT	20.12.2006
	CH	20.12.2006
	DK	20.12.2006
	FI	20.12.2006
	LI	20.12.2006
	NL	20.12.2006
	SE	20.03.2007
	GR	21.03.2007
	PT	24.04.2007
	IE	08.08.2007
	MC	31.08.2007
Former [2008/22]	AT	20.12.2006
	CH	20.12.2006
	DK	20.12.2006
	FI	20.12.2006
	LI	20.12.2006
	NL	20.12.2006
	SE	20.03.2007
	GR	21.03.2007
	PT	24.04.2007
	MC	31.08.2007
Former [2007/47]	AT	20.12.2006
	CH	20.12.2006
	DK	20.12.2006
	FI	20.12.2006
	LI	20.12.2006
	NL	20.12.2006
	SE	20.03.2007
	PT	24.04.2007
Former [2007/43]	AT	20.12.2006
	CH	20.12.2006
	FI	20.12.2006
	LI	20.12.2006
	NL	20.12.2006
	SE	20.03.2007
	PT	24.04.2007
Former [2007/30]	AT	20.12.2006
	CH	20.12.2006
	FI	20.12.2006
	LI	20.12.2006
	SE	20.03.2007
Former [2007/27]	AT	20.12.2006
	FI	20.12.2006
	SE	20.03.2007
Documents cited:	Search	[A]CH574409 (SANDOZ AG) [A] * claim 1 *;
		[A]US4618683 (DEBERNARDIS JOHN F [US], et al) [A] * column 1, line 15 - line 55 *;
		[A]US4851399 (PHILLIPPS GORDON H [GB], et al) [A] * column 3, line 34 - line 46 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p